Title:
NUCLEOTIDE DERIVATIVE OF DEUTERATED HCV NS5B INHIBITOR AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2017/118355
Kind Code:
A1
Abstract:
Provided in the present application are a nucleotide derivative of a deuterated HCV (Hepatitis C Virus) NS5b inhibitor, or a pharmaceutically acceptable salt, stereoisomer, tauromer inhibitor thereof, and a use thereof in the preparation of drugs for treating or preventing HCV infections. The inhibitor is represented by general formula (I).
Inventors:
WANG ZHE (CN)
ZENG ZHIHONG (CN)
JIANG RONGZHEN (CN)
ZENG ZHIHONG (CN)
JIANG RONGZHEN (CN)
Application Number:
PCT/CN2016/113815
Publication Date:
July 13, 2017
Filing Date:
December 30, 2016
Export Citation:
Assignee:
LONGWOOD BIOPHARMACEUTICALS LTD (CN)
International Classes:
C07H19/10; A61K31/7064; A61P31/18; A61P35/00; C07H1/00
Domestic Patent References:
WO2015116248A1 | 2015-08-06 | |||
WO2014169280A2 | 2014-10-16 |
Foreign References:
CN104672288A | 2015-06-03 |
Attorney, Agent or Firm:
BEIJING INTELLEGAL INTELLECTUAL PROPERTY AGENT LTD. (CN)
Download PDF:
Previous Patent: SYSTEM AND METHOD FOR DEVELOPING SENSE OF RHYTHM
Next Patent: TEXT IMAGE PROCESSING METHOD AND APPARATUS
Next Patent: TEXT IMAGE PROCESSING METHOD AND APPARATUS